Literature DB >> 31021953

Regulation of virulence and antibiotic resistance in Gram-positive microbes in response to cell wall-active antibiotics.

Jessica J Evans1, Devin D Bolz1,2.   

Abstract

PURPOSE OF REVIEW: Antibiotic stress can evoke considerable genotypic and phenotypic changes in Gram-positive bacteria. Here, we review recent studies describing altered virulence expression in response to cell wall-acting antibiotics and discuss mechanisms that coordinate regulation of the antibiotic response. RECENT
FINDINGS: Pleiotropic effects induced by antibiotic exposure include alterations to bacterial metabolism, cell wall structure and antibiotic resistance. In addition, subinhibitory concentrations of cell wall-active (CWA) antibiotics have increasingly been shown to induce the production of exotoxins and biofilm formation that may influence virulence. Remarkably, phenotypes associated with comparable antibiotic stresses can vary considerably, emphasizing the need to better understand the response to CWA antibiotics. Recent studies support both direct antibiotic recognition and recognition of antibiotic-induced stress to the bacterial cell wall. Specifically, bacterial two-component systems, penicillin-binding protein and serine/threonine kinase-associated kinases and conserved oxidative-stress sensors each contribute to modulating the antibiotic stress response.
SUMMARY: Bacterial sensory systems and global regulators coordinate signaling in response to CWA antibiotics. Regulation of the antibiotic response is complex and involves integration of signals from multiple response pathways. A better definition of the antibiotic stress response among Gram-positive pathogens may yield novel therapeutic targets to counter antibiotic resistance and virulence factor expression.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31021953      PMCID: PMC6652212          DOI: 10.1097/QCO.0000000000000542

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  63 in total

Review 1.  The world of subinhibitory antibiotic concentrations.

Authors:  Julian Davies; George B Spiegelman; Grace Yim
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

2.  Selective pharmacologic inhibition of a PASTA kinase increases Listeria monocytogenes susceptibility to β-lactam antibiotics.

Authors:  Daniel A Pensinger; Matthew T Aliota; Adam J Schaenzer; Kyle M Boldon; Israr-ul H Ansari; William J B Vincent; Benjamin Knight; Michelle L Reniere; Rob Striker; John-Demian Sauer
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  The Spx regulator modulates stress responses and virulence in Enterococcus faecalis.

Authors:  Jessica K Kajfasz; Jorge E Mendoza; Anthony O Gaca; James H Miller; Kristy A Koselny; Marcia Giambiagi-Demarval; Melanie Wellington; Jacqueline Abranches; José A Lemos
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

4.  Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system.

Authors:  Hiroko Kuroda; Makoto Kuroda; Longzhu Cui; Keiichi Hiramatsu
Journal:  FEMS Microbiol Lett       Date:  2007-03       Impact factor: 2.742

5.  Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile.

Authors:  Meena Sachdeva; Jennifer A Leeds
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

6.  A eukaryotic-like Ser/Thr kinase signals bacteria to exit dormancy in response to peptidoglycan fragments.

Authors:  Ishita M Shah; Maria-Halima Laaberki; David L Popham; Jonathan Dworkin
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

7.  Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus.

Authors:  Adriana Renzoni; William L Kelley; Christine Barras; Antoinette Monod; Elzbieta Huggler; Patrice François; Jacques Schrenzel; René Studer; Pierre Vaudaux; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

8.  A novel STK1-targeted small-molecule as an "antibiotic resistance breaker" against multidrug-resistant Staphylococcus aureus.

Authors:  Sashi Kant; Shailendra Asthana; Dominique Missiakas; Vijay Pancholi
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

9.  A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the Listeria monocytogenes PASTA kinase PrkA.

Authors:  Adam J Schaenzer; Nathan Wlodarchak; David H Drewry; William J Zuercher; Warren E Rose; Rob Striker; John-Demian Sauer
Journal:  J Biol Chem       Date:  2017-08-16       Impact factor: 5.157

10.  The cell wall-targeting antibiotic stimulon of Enterococcus faecalis.

Authors:  Jacqueline Abranches; Pamella Tijerina; Alejandro Avilés-Reyes; Anthony O Gaca; Jessica K Kajfasz; José A Lemos
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more
  4 in total

Review 1.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

Review 2.  Novel Strategies to Combat Bacterial Biofilms.

Authors:  Fatemeh Hemmati; Mohammad Ahangarzadeh Rezaee; Saba Ebrahimzadeh; Leila Yousefi; Roghayeh Nouri; Hossein Samadi Kafil; Pourya Gholizadeh
Journal:  Mol Biotechnol       Date:  2021-04-29       Impact factor: 2.695

3.  Antibacterial and Antibiofilm Activities of Novel Cyclic Peptides against Methicillin-Resistant Staphylococcus aureus.

Authors:  Guoxing Wei; Yun He
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

4.  The In Vitro Antimicrobial and Antibiofilm Activities of Lysozyme against Gram-Positive Bacteria.

Authors:  Fang Liu; Xing Wang; Lijie Huang; Xinling Wang; Lili Kong; Jinyou Duan; Xiaoli Zhang; Haibo Mu; Jianguo He
Journal:  Comput Math Methods Med       Date:  2022-08-10       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.